GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.880
-0.100 (-3.36%)
At close: Jan 22, 2026, 4:00 PM EST
3.049
+0.169 (5.87%)
After-hours: Jan 22, 2026, 7:58 PM EST

GeoVax Labs Revenue

GeoVax Labs had revenue of $3.35M in the twelve months ending September 30, 2025. In the year 2024, GeoVax Labs had annual revenue of $3.95M.

Revenue (ttm)
$3.35M
Revenue Growth
+8.52%
P/S Ratio
0.53
Revenue / Employee
$197,268
Employees
17
Market Cap
4.95M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.95M--
Dec 31, 2023---
Dec 31, 202281.53K-303.98K-78.85%
Dec 31, 2021385.50K-1.44M-78.86%
Dec 31, 20201.82M647.76K55.09%
Dec 31, 20191.18M212.69K22.08%
Dec 31, 2018963.20K-112.07K-10.42%
Dec 31, 20171.08M246.35K29.72%
Dec 31, 2016828.92K400.84K93.64%
Dec 31, 2015428.08K-454.88K-51.52%
Dec 31, 2014882.96K-1.53M-63.48%
Dec 31, 20132.42M-239.78K-9.02%
Dec 31, 20122.66M-2.24M-45.77%
Dec 31, 20114.90M-285.37K-5.50%
Dec 31, 20105.19M1.52M41.36%
Dec 31, 20093.67M758.03K26.05%
Dec 31, 20082.91M2.67M1,127.90%
Dec 31, 2007237.00K-615.90K-72.21%
Dec 31, 2006852.91K182.44K27.21%
Dec 31, 2005670.47K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cyclerion Therapeutics2.86M
Lyra Therapeutics600.00K
Can-Fite BioPharma560.00K
VivoSim Labs140.00K
Silo Pharma72.10K
Revenue Rankings